
Breakthrough in Blood Cancer Treatment: Single-Dose CAR-T Shows Promise
A new CAR-T immunotherapy developed by Legend Biotech and marketed by Johnson & Johnson has shown promising results in treating advanced multiple myeloma, with about a third of patients experiencing long-term remission, prompting discussions of a potential cure for this previously incurable blood cancer.


